Novel Coronavirus (SARS-CoV-2/COVID-19)

The Centers for Medicare & Medicaid Services released a guide for patients considering in-person, non-emergency treatment as the country continues to reopen and COVID-19 cases decline.
The Department of Health and Human Services announced in an email that it is planning an additional distribution of funds to hospitals that have been particularly affected by the increased burden of caring for those with COVID-19.
The Department of Health and Human Services announced that it will distribute $10 billion from the Public Health and Social Services Emergency Fund to hospitals that serve a disproportionate number of Medicaid patients or provide large amounts of uncompensated care. 
The Department of Health and Human Services (HHS) today announced that it will distribute $10 billion from the Public Health and Social Services Emergency Fund to hospitals that serve a disproportionate number of Medicaid patients or provide large amounts of uncompensated care.
The Department of Health and Human Services (HHS) yesterday announced in an email that it is planning an additional $10 billion distribution of funds to hospitals that have been particularly affected by the increased burden of caring for those with COVID-19. To inform how these funds are…
COVID-19 may be an invisible enemy that threatens all people, but evidence is mounting that it is disproportionately more lethal to racial and ethnic minorities and the poor as well as those with chronic conditions like diabetes. To address these disparities, hospitals and health systems and…
If you’re wondering how significant the long-term impact of the soaring use of telehealth services during the COVID-19 pandemic could be on health care, a new analysis from McKinsey & Co. pegs the number at $250 billion.
On June 17 at 1 p.m. ET, the AHA and Avia Health Innovation will host a webinar during which experts will share how hospitals and health systems successfully have deployed digital solutions to provide access to behavioral health care treatment during the COVID-19 pandemic.
FDA released new guidance that expands for the duration of the COVID-19 emergency the availability and capability of non-invasive monitoring devices.